Mattison, Donald R.
University of Ottawa · University of South Carolina
5 papers on CoChatORCID 0000-0001-5623-0874
Most cited papers
- Verified
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics
Sex and Gender in HealthcarePharmacogenetics and Drug Metabolism
Cited by 1,163
- Verified
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs
Moore, T. J., Glenmullen, J., & Mattison, D. R. (2014) · JAMA Internal Medicine
Pharmacovigilance and Adverse Drug ReactionsParkinson's Disease Mechanisms and Treatments
Cited by 324
- Verified
Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race
Moore, T. J., & Mattison, D. R. (2017) · JAMA Internal Medicine
Mental Health Treatment and AccessPharmaceutical Practices and Patient Outcomes
Cited by 207
- Verified
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
Alami, A., Krewski, D., Farhat, N., Mattison, D., Wilson, K., Gravel, C. A., Farrell, P. J., Crispo, J. A. G., Haddad, N., Perez-Lloret, S., et al. (2023) · BMJ Open
Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research
Cited by 44
- Verified
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom
Otero-Losada, M., Petrovsky, N., Alami, A., Crispo, J. A., Mattison, D., Capani, F., Goetz, C., Krewski, D., & Perez-Lloret, S. (2023) · Expert Opinion on Drug Safety
SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free